SCHEMBL8718582

SCHEMBL8718582

C=Cc1cccc(-c2nc(-c3ccc(NC)cc3)c(-c3ccc(N4CCCC4)cc3)[nH]2)c1-c1nc2ccccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ MAPT P10636 4/20 0.40
▸ HPGD P15428 5/20 0.39
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ NPC1 O15118 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ STAT1 P42224 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ USP2 O75604 2/20 0.34
▸ PTPN2 P17706 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ PTPN5 P54829 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8720952 0.86 MAPT (0.43) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL8723120 0.84 MAPT (0.36) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL3825381 0.83 KDM4E (0.36) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL3824756 0.72 SELP (0.40) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL3824090 0.71 SELP (0.41) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL3824183 0.68 NOX1 (0.45) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL5708149 0.68 TOP2A (0.49) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL3830694 0.66 MEN1 (0.37) MAPTHTTNPSR1NPC1RAB9A
SCHEMBL1660542 0.65 NPC1 (0.67) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL16448288 0.62 ABCB1 (0.68) ALDH1A1MAPTHTTSMN1; SMN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback